MEDIA release
May 02, 2025
Medical Product Alert – Falsified HEALMOXY (Amoxicillin) Capsules 500mg
Port of Spain, May 02, 2025: The Ministry of Health (MoH), via its Drug Inspectorate Division advises of the WHO Medical Product Alert of four batches of falsified HEALMOXY Capsules 500mg. The active pharmaceutical ingredient in genuine HEALMOXY capsules is amoxicillin: it is an antibiotic used to treat a variety of bacterial infections, including middle ear infections, pneumonia, skin infections, dental infections, and urinary tract infections.
The WHO Alert, stated that the falsified products have been detected in Cameroon and the Central African Republic. The alert further stated that the falsified products are unsafe and may pose significant health risks, particularly for severe infections or vulnerable individuals.
The falsified product can be identified by the misrepresentation of their identity, composition, and source:
· Analysis of samples of the falsified HEALMOXY found the capsules did not contain the stated active ingredient, specifically, amoxicillin.
· At least two of the falsified products display inconsistent formats for manufacture and expiry dates. Dates on these falsified products are displayed as day/month/year in eight digits (e.g., 10/01/2027).
While the product is not registered for use in Trinidad and Tobago nor has any authorisation for import been issued. Out of an abundance of caution, the Ministry advises persons who may be in possession of the drug to discontinue use immediately.
Additional information can be obtained by contacting the Office of the Principal Pharmacist, Drug Inspectorate via email at druginspectorate@health.gov.tt or phone at 217-4664 ext. 13401.
###
